Skip to content

Grow Your Practice with AdaptDx Pro

AdaptDx Pro Helps You Identify Additional AMD Patients

The initial test takes less than 6.5 minutes, and can be performed during dilation. The portable headset minimizes patient disruption. You can even use more than one device to run multiple tests at the same time.

By testing your patients with AdaptDx Pro, you may uncover new cases of subclinical and early AMD. In fact, current users see as many as 30-40% of patients over 50 years old with night vision complaints fail the AdaptDx Pro Rapid Test—indicating impaired dark adaptation, a biomarker for AMD.

Once AMD is detected, dark adaptation testing allows you to monitor disease progression at regular intervals. In turn, more frequent visits and proactive treatment often results in improved outcomes and patient compliance—and has the potential for boosting practice revenue.

Identifying AMD patients may also elicit extra income from sales of nutraceuticals, blue light blocking lenses and protective sunglasses. Each AdaptDx Pro purchase is supported by our AMD Excellence Program® – a core component of every device subscription. 

Empowering Eye Care Technicians as AMD Champions

 

Dark Adaptation Testing is Reimbursable

  • CPT Code 92284 for dark adaptation
  • $60.02 average national reimbursement 
  • Co-billable with OCT, fundus imaging, visual field, and/or office visits
  • Multiple ICD-10 codes based on medical necessity 

 

Thanks to the comprehensive AMD Excellence training program from MacuLogix, each staff member - from the front desk and optical, to technicians and billing - understands the important role they play in AMD care.

R. Aaron Werner Aaron Werner, OD View all testimonials

Put Our Expertise to Work

Enhance Patient Care

A diagnosis of subclinical AMD may increase the chances of delaying or preventing vision loss associated with the disease.

Implementation Expertise

Each AdaptDx Pro purchase is supported by our AMD Excellence Program®️ to help you achieve your practice growth goals.